Patients with complex chronic cough reported high satisfactory levels with virtual consultations.
Virtual visits to Emory University’s Multidisciplinary Chronic Cough Clinic (MDCCC) via synchronous, 2-way audiovisual encounters demonstrated effectiveness in managing patients with complex chronic cough in lieu of in-person consultations during the COVID-19 pandemic.
Data from 30 virtual MDCCC consultations for patients with refractory chronic cough before management were evaluated in research published in International Forum of Allergy & Rhinology. Patients had a mean age of 60.2 years and mean cough duration of 5.2 years. The mean Cough Severity Index score, available for 26 of the patients, was 23.72 of 40, suggesting significant baseline symptoms.
The primary underlying cough diagnoses were cough hypersensitivity syndrome (CHS), consistent with neurogenic cough/irritable larynx syndrome in 13 (43.3%) patients, reflux/esophageal dysmotility in 13 (43.3%), and unrecognized angiotensin-converting enzyme inhibitor use, asthma, interstitial lung disease, and chronic eosinophilic pneumonia in 1 (0.03%) each. Associated possible contributors and secondary diagnoses included CHS in 10 (33.3%) patients, gastroesophageal reflux disease in 2 (0.06%), asthma in 2 (0.06%), and upper airway cough syndrome in 1 (0.06%).
During the virtual consultations, providers administered limited examinations and gathered patient information to determine their present illness and past medical histories. Specialists across different health care sectors, including allergy, immunology, pulmonology, interventional pulmonology, gastroenterology, otolaryngology, and speech-language pathology, collaborated to formulate clinical plans and recommend further testing based on this initial evaluation.
Interprofessional collaboration within the virtual MDCCC allowed patients to see upward of 5 providers simultaneously while maintaining clinical efficiency.
Patients were contacted to complete a postencounter survey consisting of 5 questions rating satisfaction levels with their virtual consultation on a scale from 0 to 10. Of the 30 patients who received virtual consultations, 17 (56%) responded.
The authors’ findings showed:
Although the survey results demonstrated that the virtual MDCCC provides efficient services for patients with chronic cough, “a larger study is needed to show the benefits of this care model, including streamlined diagnosis, patient outcomes, and decreased health care costs,” the authors concluded.
Unexplained chronic cough, as defined by a persistent cough lasting more than 8 weeks, is a significant problem, with 5% to 10% patients seeking medical assistance and 46% patients receiving referrals to specialists. Due to its multifactorial nature, determining the etiology and management of chronic cough is challenging. These challenges often lead to fragmented evaluation by different medical specialties, excessive testing, and duplication of efforts.
Reference
Kuruvilla M, Hatcher J, Shelly S, et al. Virtual interprofessional chronic cough clinic: An efficient and appealing approach to a complex problem. Int Forum Allergy Rhinol. Published online April 17, 2021. doi:10.1002/alr.22805
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More